Discontinued — last reported Q3 '25
NiSource Equity Method Investments increased by 1.2% to $8.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 20.6%, from $6.80M to $8.20M.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $800.00K | $800.00K | $800.00K | $1.60M | $1.60M | $2.20M | $3.80M | $5.20M | $5.30M | $5.40M | $5.40M | $6.50M | $6.50M | $6.80M | $7.80M | $7.70M | $8.10M | $8.20M |
| QoQ Change | — | +0.0% | +0.0% | +100.0% | +0.0% | +37.5% | +72.7% | +36.8% | +1.9% | +1.9% | +0.0% | +20.4% | +0.0% | +4.6% | +14.7% | -1.3% | +5.2% | +1.2% |
| YoY Change | — | — | — | — | +100.0% | +175.0% | +375.0% | +225.0% | +231.3% | +145.5% | +42.1% | +25.0% | +22.6% | +25.9% | +44.4% | +18.5% | +24.6% | +20.6% |